181 related articles for article (PubMed ID: 8092829)
21. [Curative antifungal treatment of invasive pulmonary aspergillosis].
Andrès E; Courouau F; Kurtz JE; Limacher JM; Quoix E
Rev Pneumol Clin; 1995; 51(4):228-31. PubMed ID: 7501940
[TBL] [Abstract][Full Text] [Related]
22. In-vitro and in-vivo susceptibility of Aspergillus fumigatus to a novel conjugated styryl ketone.
Manavathu EK; Dimmock JR; Vashishtha SC; Cutright J; Chandrasekar PH
J Antimicrob Chemother; 1998 Nov; 42(5):585-90. PubMed ID: 9848441
[TBL] [Abstract][Full Text] [Related]
23. Comparison of azoles against aspergilli in vitro and in an experimental model of pulmonary aspergillosis.
Schmitt HJ; Edwards F; Andrade J; Niki Y; Armstrong D
Chemotherapy; 1992; 38(2):118-26. PubMed ID: 1317280
[TBL] [Abstract][Full Text] [Related]
24. Tissue distribution and antifungal effect of liposomal itraconazole in experimental cryptococcosis and pulmonary aspergillosis.
Le Conte P; Joly V; Saint-Julien L; Gillardin JM; Carbon C; Yeni P
Am Rev Respir Dis; 1992 Feb; 145(2 Pt 1):424-9. PubMed ID: 1310577
[TBL] [Abstract][Full Text] [Related]
25. Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia.
Petraitiene R; Petraitis V; Groll AH; Sein T; Schaufele RL; Francesconi A; Bacher J; Avila NA; Walsh TJ
Antimicrob Agents Chemother; 2002 Jan; 46(1):12-23. PubMed ID: 11751105
[TBL] [Abstract][Full Text] [Related]
26. Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis.
Lewis RE; Liao G; Hou J; Chamilos G; Prince RA; Kontoyiannis DP
Antimicrob Agents Chemother; 2007 Apr; 51(4):1253-8. PubMed ID: 17261624
[TBL] [Abstract][Full Text] [Related]
27. Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis model.
Olson JA; Adler-Moore JP; Schwartz J; Jensen GM; Proffitt RT
Antimicrob Agents Chemother; 2006 Jun; 50(6):2122-31. PubMed ID: 16723574
[TBL] [Abstract][Full Text] [Related]
28. Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B.
Warn PA; Morrissey G; Morrissey J; Denning DW
J Antimicrob Chemother; 2003 Apr; 51(4):913-9. PubMed ID: 12654746
[TBL] [Abstract][Full Text] [Related]
29. In-vivo itraconazole resistance of Aspergillus fumigatus in systemic murine aspergillosis. EBGA Network. European research group on Biotypes and Genotypes of Aspergillus fumigatus.
Dannaoui E; Borel E; Persat F; Monier MF; Piens MA; Network E
J Med Microbiol; 1999 Dec; 48(12):1087-1093. PubMed ID: 10591162
[TBL] [Abstract][Full Text] [Related]
30. A comparison of the efficacy of itraconazole, amphotericin B and 5-fluorocytosine in the treatment of Aspergillus fumigatus endocarditis in the rabbit.
Longman LP; Martin MV
J Antimicrob Chemother; 1987 Nov; 20(5):719-24. PubMed ID: 2828301
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of micafungin alone or in combination against experimental pulmonary aspergillosis.
Clemons KV; Stevens DA
Med Mycol; 2006 Feb; 44(1):69-73. PubMed ID: 16805095
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic monitoring of experimental invasive pulmonary aspergillosis by ultrafast computerized tomography, a novel, noninvasive method for measuring responses to antifungal therapy.
Walsh TJ; Garrett K; Feurerstein E; Girton M; Allende M; Bacher J; Francesconi A; Schaufele R; Pizzo PA
Antimicrob Agents Chemother; 1995 May; 39(5):1065-9. PubMed ID: 7625790
[TBL] [Abstract][Full Text] [Related]
33. Combination therapy in a model of pulmonary aspergillosis.
Schmitt HJ; Bernard EM; Edwards FF; Armstrong D
Mycoses; 1991; 34(7-8):281-5. PubMed ID: 1803227
[TBL] [Abstract][Full Text] [Related]
34. Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B.
Walsh TJ; Petraitis V; Petraitiene R; Field-Ridley A; Sutton D; Ghannoum M; Sein T; Schaufele R; Peter J; Bacher J; Casler H; Armstrong D; Espinel-Ingroff A; Rinaldi MG; Lyman CA
J Infect Dis; 2003 Jul; 188(2):305-19. PubMed ID: 12854088
[TBL] [Abstract][Full Text] [Related]
35. Liposomal nystatin against experimental pulmonary aspergillosis in persistently neutropenic rabbits: efficacy, safety and non-compartmental pharmacokinetics.
Groll AH; Gonzalez CE; Giri N; Kligys K; Love W; Peter J; Feuerstein E; Bacher J; Piscitelli SC; Walsh TJ
J Antimicrob Chemother; 1999 Jan; 43(1):95-103. PubMed ID: 10381106
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of intravenous itraconazole against experimental pulmonary aspergillosis.
Miyazaki HM; Kohno S; Miyazaki Y; Mitsutake K; Tomono K; Kaku M; Koga H; Hara K
Antimicrob Agents Chemother; 1993 Dec; 37(12):2762-5. PubMed ID: 8109952
[TBL] [Abstract][Full Text] [Related]
37. Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B.
Harousseau JL; Dekker AW; Stamatoullas-Bastard A; Fassas A; Linkesch W; Gouveia J; De Bock R; Rovira M; Seifert WF; Joosen H; Peeters M; De Beule K
Antimicrob Agents Chemother; 2000 Jul; 44(7):1887-93. PubMed ID: 10858349
[TBL] [Abstract][Full Text] [Related]
38. [Invasive aspergillosis in surgical intensive care patients].
Blanloeil Y; François T; Germaud P; Le Conte P; Morin O; Michel P; Levron JC; Dixneuf B
Ann Fr Anesth Reanim; 1993; 12(4):379-84. PubMed ID: 8273926
[TBL] [Abstract][Full Text] [Related]
39. Caspofungin: new preparation. A last resort in invasive aspergillosis.
Prescrire Int; 2002 Oct; 11(61):142-3. PubMed ID: 12378745
[TBL] [Abstract][Full Text] [Related]
40. Clinical efficacy of micafungin for chronic pulmonary aspergillosis.
Izumikawa K; Ohtsu Y; Kawabata M; Takaya H; Miyamoto A; Sakamoto S; Kishi K; Tsuboi E; Homma S; Yoshimura K
Med Mycol; 2007 May; 45(3):273-8. PubMed ID: 17464848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
